Australian Advantage

Outsourcing clinical trials to Australia delivers a powerful combination of cost efficiency, speed, and quality — when done properly.

​

Australia offers globally competitive R&D tax incentives that can materially reduce the cost of clinical development and extend sponsor runway. However, eligibility and compliance requirements continue to evolve. BaseBio works closely with sponsors to ensure trial design, vendor selection, and operational structures are aligned with current R&D tax guidance — maximising value while avoiding downstream risk.

​

Australia’s clinical trial environment is also fast and flexible. Early-phase studies can commence rapidly under the CTN/CTA framework, with no mandatory IND submission and pragmatic GMP expectations appropriate for early development. This allows sponsors to move efficiently without compromising scientific or regulatory integrity.

​

Just as importantly, Australia delivers quality. A mature ecosystem of experienced investigators, leading Phase I units, specialised CROs, and world-class research institutions underpin consistent, high-quality trial execution.

​

With the right local expertise, Australia is not just a lower-cost option — it is a strategic accelerator.

BaseBio provides on-the-ground clinical operations leadership to help sponsors place, operationalise and deliver trials in Australia with confidence.

​